Isoquinoline alkaloids and their binding with polyadenylic acid: Potential basis of therapeutic action

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 7, 2010, Pages 568-577

  Giri, Prabal ^a,b   Kumar, Gopinatha Suresh ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Guskara Mahavidyalaya ^*  (India)

Author keywords

Alkaloids; Binding; Calorimetry; Polyadenylic acid; Spectroscopy

Indexed keywords

BERBERINE; CORALYNE; ISOQUINOLINE ALKALOID; PALMATINE; POLYADENYLIC ACID; ALKALOID; INTERCALATING AGENT; ISOQUINOLINE DERIVATIVE; MESSENGER RNA;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BINDING; DRUG DESIGN; DRUG RESEARCH; DRUG TARGETING; EUKARYOTIC CELL; GASTROENTERITIS; GENE TARGETING; INTERCALATION COMPLEX; MEDICINAL CHEMISTRY; PHYSICAL CHEMISTRY; REVIEW; RNA TRANSLATION; SKIN LEISHMANIASIS; STATIC ELECTRICITY; STOICHIOMETRY; THERMODYNAMICS; CHEMISTRY; CIRCULAR DICHROISM; HUMAN;

ALKALOIDS; CALORIMETRY, DIFFERENTIAL SCANNING; CIRCULAR DICHROISM; HUMANS; INTERCALATING AGENTS; ISOQUINOLINES; POLY A; RNA, MESSENGER;

EID: 77955952570     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955710791384009     Document Type: Review

References (88)

1. Denny, W.A. DNA-intercalating ligands as anti-cancer drugs: prospects for future design. Anticancer Drug Des., 1989, 4, 241-263.
2. Hurley, L.H. DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer, 2002, 2, 188-200.
3. Maiti, M.; Kumar, G.S. Biophysical aspects and biological implications of the interaction of benzophenanthridine alkaloids with DNA. Biophys. Rev., 2009, 1, 119-129.
4. Schmeller, T.; Latz-Bruning, B.; Wink, M. Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry, 1997, 44, 257-266.
5. Chen, W.H.; Chan, C.L.; Cai, Z.; Luo, G.A.; Jiang, Z.H. Study on noncovalent complexes of cytotoxic protoberberine alkaloids with double-stranded DNA by using electrospray ionization mass spectrometry. Bioorg. Med. Chem. Lett., 2004, 14, 4955-4959.
6. Upton, R. Valeriana officinalis. J. Alt. Complement. Med., 2001, 7, 15-17.
7. Mambu, L.; Ramnandraibe, V.; Martin, M.T.; Blond, A.; Frappier, F. Constituents of Burasaïa madagascarensis: a new clerodane-type diterpene. Planta Med., 2002, 68, 377-378.
8. Dostal, J; Slavik, J. Recent knowledge on sanguinarine and related alkaloids. Chem. Listy, 2000, 94, 15-20.
9. Chrzanowska, M; Rozwadowska, M.D. Asymmetric synthesis of isoquinoline alkaloids. Chem. Rev., 2004, 104, 3341-3370.
10. Zdarilova, A.; Malikova, J.; Dvorak, Z.; Ulrichova, J; Simanek, V. Quaternary isoquinoline alkaloids sanguinarine and chelerythrine. In vitro and in vivo effects. Chem. Listy, 2006, 100, 30-41.
11. Grycova, L.; Dostal, J.; Marek R. Quaternary protoberberine alkaloids. Phytochemistry, 2007, 68, 150-175.
12. Wink, M. In The Alkaloids: Chemistry and Biology, G.A. Cordell, Ed.; Elsevier Science, New York, 2007, vol. 64, pp. 1-47.
13. Reimann, E. Recent strategies for the synthesis of protoberberines and protoberberine type compounds. Curr. Org. Chem., 2009, 13, 353-378.
14. Sanger, W. Principles of Nucleic Acid Structure, Springer-Verlag: New York, 1984.
15. Wilson, W.D.; Li K. Targeting RNA with small molecules. Curr. Med. Chem., 2000, 7, 73-98.
16. Gallego, J.; Varani, G. Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges. Acc. Chem. Res., 2001, 34, 836-843.
17. Tor, Y. Targeting RNA with small molecules. ChemBioChem, 2003, 4, 998-1007.
18. Vicens, Q.; Westhof, E. RNA as a drug target: the case of aminoglycosides ChemBioChem, 2003, 4, 1018-1023.
19. Munroe, D.; Jacabson, A. mRNA poly(A) tail, a 3' enhancer of translational initiation. Mol. Cell Biol., 1990, 10, 3441-3455.
20. Decker, C.J.; Parker, R. A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev., 1993, 7, 1632-1643
21. Wang, Z.; Day, N.; Trifillis, P.; Kiledjian, M. An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. Mol. Cell Biol., 1999, 19, 4552-4560.
22. Chen, Z.; Li, Y.; Krug, R.M. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J., 1999, 18, 2273-2283.
23. Tian, B.; Hu, J.; Zhang, H.; Lutz, C.S. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res., 2005, 33, 201-212.
24. Craig, A.W.B.; Haghighat, A.; Yu, A.T.K.; Sonenberg, N. Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation. Nature, 1998, 392, 520-523.
25. Maniatis, T.; Reed, R. An extensive network of coupling among gene expression machines. Nature, 2002, 416, 499-506.
26. Neugebauer, K.M. On the importance of being co-transcriptional. J. Cell Sci., 2002, 115, 3865-3871
27. Calvo, O.; Manley, J.L. Strange bedfellows: polyadenylation factors at the promoter. Genes Dev., 2003, 17, 1321-1327.
28. Proudfoot, N. New perspectives on connecting messenger RNA 3' end formation to transcription. Curr. Opin. Cell Biol., 2004, 16, 272-278.
29. Fuke, M.; Ohno, M. Role of poly (A) tail as an identity element for mRNA nuclear export. Nucleic Acids Res., 2007, 36, 1037-1049.
30. Topalian, S.L.; Kaneko, S.; Gonzales, M.I.; Bond, G.; Ward, Y.; Manley, J.L. Identification and functional characterization of neopoly (A) polymerase, an RNA processing enzyme over expressed in human tumors. Mol. Cell. Biol., 2001, 21, 5614-5623.
31. Topalian, S.L.; Gonzales, M.I.; Ward, Y.; Wang, X.; Wang, R.F. Revelation of acryptic major histocompatibility complex class IIrestricted tumor epitope in a novel RNA processing enzyme. Cancer Res., 2002, 62, 5505-5509.
32. Xing, F.; Song, G.; Ren, J.; Chaires, J.B. Molecular recognition of nucleic acids: coralyne binds strongly to poly(A). FEBS Lett., 2005, 579, 5035-5039.
33. Giri, P.; Kumar G.S. Molecular aspects of small molecules-poly(A) interaction: An approach to RNA based drug design. Curr. Med. Chem., 2009, 16, 965-987.
34. Giri, P.; Kumar G.S. Molecular recognition of poly(A) targeting by protoberberine alkaloids: in vitro biophysical and biological perspectives. Mol. BioSyst., 2010, 6, 81-88.
35. Xi, H.; Gray, D.; Kumar, S.; Arya, D.P. Molecular recognition of single-stranded RNA: Neomycin binding to poly(A). FEBS Lett., 2009, 583, 2269-2275.
36. Fresco, J.R.; Doty, P. Polynucleotides.I. Molecular properties and configurations of polyriboadenylic acid in solution. J. Am. Chem. Soc., 1957, 79, 3928-3929.
37. Holcomb, D.N.; Tinoco, I. Conformation of polyriboadenylic acid: pH and temperature dependence. Biopolymers, 1965, 3, 121-133.
38. Leng, M.; Felsenfeld, G. A study of polyadenylic acid at neutral pH. J. Mol. Biol., 1966, 15, 455-466.
39. Petrovic, A.; Polavarapu, P.L. Structural transitions in polyriboadenylic acid induced by the changes in pH and temperature: vibrational circular dichroism study in solution and film states. J. Phy. Chem. B, 2005, 109, 23698-705.
40. Zarudnaya, M.I.; Hovorun, D.M. Hypothetical double-helical poly(A) formation in a cell and its possible biological significance. IUBMB Life, 1999, 48, 581-584.
41. Zarudnaya, M.I.; Kolomiets, I.M.; Potyahaylo, A.L.; Hovorun D.M. Downstream elements of mammalian pre-mRNA polyadenylation signals: primary, secondary and higher-order structures. Nucleic Acids Res., 2003, 31, 1375-1386.
42. Ravindranathan, S.; Butcher, S.E.; Feigon, J. Adenine protonation in domain B of the hairpin ribozyme. Biochemistry, 2000, 39, 16026-16032.
43. Ivanovska, N.; Philipov, S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int. J. Immunopharmacol., 1996, 18, 553-561.
44. Kuo, C. L.; Chou, C.C.; Yung, B. Y. M.; Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett., 1995, 93, 193-200.
45. Wu H. L.; Hsu, C. Y.; Liu, W. H.; Yung, B. Y. M.; Berberineinduced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int. J. Cancer, 1999, 81, 923-929.
46. Suffness, M.; Cordell, G.A. The Alkaloids, Academic press: Orlando, 1985, vol. 15, pp. 198-212, 338-340.
47. Debnath, D.; Kumar, G. S.; Nandi, R.; Maiti, M. Interaction of berberine chloride with deoxyribonucleic acids: evidence for base and sequence specificity. Indian J. Biochem. Biophys., 1989, 26, 201-208.
48. Debnath, D.; Kumar, G. S.; Maiti, M. Circular dichroism studies of the structure of DNA complex with berberine. J. Biomol. Struct. Dyn., 1991, 9, 61-79.
49. Saran, A.; Srivastava, S.; Coutinho, E.; Maiti, M. 1H NMR investigation of the interaction of berberine and sanguinarine with DNA. Indian J. Biochem. Biophys., 1995, 32, 74-77.
50. Kumar, G.S.; Das, S.; Bhadra, K.; Maiti, M. Protonated forms of poly[d(G-C)] and poly(dG).poly(dC) and their interaction with berebrine. Bioorg. Med. Chem., 2003, 11, 4861-4870.
51. Nandi, R.; Debnath, D.; Maiti, M. Interactions of berberine with poly(A) and tRNA. Biochim. Biophys. Acta, 1990, 1049, 339-342.
52. Yadav, R.C.; Kumar, G.S.; Bhadra, K.; Giri, P.; Sinha, R.; Pal, S.; Maiti, M. Berberine, a strong polyriboadenylic acid binding plant alkaloid; spectroscopic, viscometric, and thermodynamic study. Bioorg. Med. Chem., 2005, 13, 165-174.
53. Giri, P.; Kumar, G.S. Self-structure induction in single stranded poly(A) by small molecules: Studies on DNA intercalators, partial intercalators and groove binding molecules. Arch. Biochem. Biophys., 2008, 474, 183-192.
54. Centikol, O.P.; Hud, N.V. Molecular recognition of poly(A) by small ligands: an alternative method of analysis reveals nanomolar, cooperative and shape-selective binding. Nucleic Acids Res., 2009, 611-621.
55. Giri, P. Biophysical studies on the interaction of plant alkaloids with polyadenylic acid structures. Ph.D Thesis, Jadavpur University, 2008.
56. Haq, I. Thermodynamics of drug-DNA interactions Part II: the thermodynamics of drug-biopolymer interaction. Arch. Biochem. Biophys., 2002, 403, 1-15.
57. Chaires, J.B. A thermodynamic signature for drug-DNA binding mode. Arch. Biochem. Biophys., 2006, 453, 26-31.
58. Chaires, J.B. Calorimetry and thermodynamics in drug design. Annu. Rev. Biophys., 2008, 37, 135-151.
59. Maiti, M.; Chaudhuri, K. Interaction of berberine chloride with naturally occurring deoxyribonucleic acids. Indian J. Biochem. Biophys., 1981, 18, 245-250.
60. Lerman, L.S. The structure of the DNA-acridine complex. Proc. Natl. Acad. Sci. U.S.A., 1963, 49, 94-102.
61. Sethi, M.L. Enzyme inhibition VI: Inhibition of reverse transcriptase activity by protoberberine alkaloids and structure-activity relationships. J. Pharm. Sci., 1983, 75, 538-541.
62. Chang, Y.L.; Usami, S.; Hsieh, M.T.; Jiang, M.J. Effects of palmatine on isometric force and intracellular calcium levels of arterial smooth muscle. Life Sci., 1999, 64, 597-606.
63. Kupeli, E.; Kosar, M.; Yesilada, E.; Baser, K.H.C.; Baser, C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci., 2002, 72, 645-657.
64. Vollekova, A.; Kostalova, D.; Kettmann, V.; Toth, J. Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids. Phytother. Res., 2003, 17, 834-837.
65. Wang, F.; Zhou, H.Y.; Cheng, L.; Zhao, G.; Zhou, J.; Fu, L.Y.; Yao, W.X. Effects of palmatine on potassium and calcium currents in isolated rat hepatocytes. World J. Gasteroenterol., 2003, 9, 329-333.
66. Giri, P.; Hossain, M.; Kuamar, G.S. RNA specific molecules: cytotoxic plant alkaloid palmatine binds strongly to poly(A). Bioorg. Med. Chem. Lett., 2006a, 16, 2364-2368.
67. Giri, P.; Hossain, M.; Kumar, G.S. Molecular aspects on the specific interaction of cytotoxic plant alkaloid palmatine to poly(A). Int. J. Biol. Macromol., 2006b, 39, 210-221.
68. Chaires, J.B. Competition dialysis: an assay to measure the structural selectivity of drug-nucleic acid interactions. Curr. Med. Chem.-Anti-Cancer Agents, 2005, 5, 339-352.
69. Ragazzon, P., Garbett, N.C.; Chaires, J.B. Competition dialysis: a method for the study of structural selective nucleic acid binding. Methods, 2007, 42,173-182.
70. McGhee, J.D.; von Hippel, P.H. Theoretical aspects of protein-DNA interactions; cooperative and non-cooperative binding of large ligands to one-dimensional homogeneous lattice. J. Mol. Biol., 1974, 86, 469-4849.
71. Benesi, H.A.; Hildebrand, J.H. A Spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J. Am. Chem. Soc., 1949, 71, 2703-2707.
72. Pilch, D.S.; Yu, C.; Makhey, D.; Lavoie, E.J.; Srinivasan, A.K.; Olson, W.K.; Sauers, R.R.; Breslauer, K.J.; Geacintov, N.E.; Liu, L.F. Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs. Biochemistry, 1997, 36, 12542-12553.
73. Zee-Chang, K.Y.; Cheng, C.C. Interaction between DNA and coralyne acetosulfate, an antileukemic compound. J. Pharm. Sci., 1973, 62, 1572-1573.
74. Gupta, R.S.; Murray, W. Gupta, R. Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line. Br. J. Cancer, 1988, 58, 441-447.
75. Gatto, B.; Sanders, M.M.; Yu, C.; Wu, H.Y.; Makhey, D.; LaVoie, E.J.; Liu, L.F. Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne. Cancer Res., 1996, 56, 2795-2800.
76. Pal, S.; Kumar, G.S; Debnath, D.; Maiti, M. Interaction of the antitumour alkaloid coralyne with duplex deoxyribonucleic acid structures: spectroscopic and viscometric studies. Indian J. Biochem. Biophys., 1998, 35, 321-332.
77. Garcia, B.; Ibeas, S.; Ruiz, R.; Leal, J.M.; Biver, T.; Boggioni, A.; Secco, F.; Venturini, M. Solvent effect on the thermodynamics and kinetics of coralyne self-aggregation. J. Phys. Chem. B, 2009, 113, 188-196.
78. Jain, S.S.; Polak, M.; Hud, N.V. Controlling nucleic acid secondary structure by intercalation: effects of DNA strand length on coralyne-driven duplex disproportionation. Nucleic Acids Res., 2003, 31, 4608-4615.
79. Persil, O.; Santai, C.T.; Jain, S.S.; Hud, N.V. Assembly of an antiparallel homo-adenine DNA duplex by small-molecule binding. J. Am. Chem. Soc., 2004, 126, 8644-8645.
80. Joung, I.S.; Cetinkol O.P.; Hud, N.V.; Cheatham, T.E. Molecular dynamics simulations and coupled nucleotide substitution experiments indicate the nature of A.A base pairing and a putative structure of the coralyne-induced homo-adenine duplex. Nucleic Acids Res., 2009, 37(22), 7715-27.
81. Giri, P.; Kumar, G.S. Binding of protoberberine alkaloid coralyne with double stranded poly(A): a biophysical study. Mol. BioSyst., 2008, 4, 341-348.
82. Lakowicz, J.R. Principles of Fluorescence Spectrosopy, Plenum Press: New York, 1983.
83. Dykxhoorn, D.M.; Novina, C.D.; Sharp, P.A. Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol., 2003, 4, 457-467.
84. Meister, G.; Tuschl, T. Mechanisms of gene silencing by doublestranded RNA. Nature, 2004, 431, 343-349.
85. Mello, C.C.; Conte, D. Revealing the world of RNA interference. Nature, 2004, 431, 338-342.
86. Maiti, M.; Kumar, G.S. Molecular aspects on the interaction of protoberberine, benzophenanthridine, and aristolochia group of alkaloids with nucleic acid structures and biological perspectives. Med. Res. Rev., 2007, 27, 649-695.
87. Maiti, M.; Kumar, G.S. In Topics in Heterocyclic Chemistry, M.T. Khan, M.T.; Ed.; Springer-Verlag, Berlin, Heidelberg, 2007; Vol. 10, pp. 155-209.
88. Maiti, M.; Kumar, G.S. Polymorphic nucleic acid binding of bioactive isoquinoline alkaloids and their role in cancer. J. Nucleic Acids, 2010, in press doi: 10.4061/2010/593408.